• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALERE SAN DIEGO, INC. MEDLINE HCG COMBO CASSETTE; VISUAL, PREGNANCY HCG, PRESCRIPTION USE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALERE SAN DIEGO, INC. MEDLINE HCG COMBO CASSETTE; VISUAL, PREGNANCY HCG, PRESCRIPTION USE Back to Search Results
Model Number FHC-A202
Device Problem False Positive Result (1227)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 11/01/2023
Event Type  malfunction  
Manufacturer Narrative
Results pending completion of the investigation.B3 - date of event: listed as 11/1/2023 as an event date was not provided.H3 other text : although requested, device return is not anticipated.
 
Event Description
The customer reported receiving several false positive hcg results while using kits from two lots of medline hcg combo cassette tests.The customer reported receiving positive results when negative results are expected.No further information was provided.No adverse events reported.See mdr 2027969-2023-00119 for lot 0000674186.
 
Manufacturer Narrative
B3 - date of event: listed as (b)(6) 2023 as an event date was not provided.D4 - expiration date: previously submitted as ni and now has been updated with the expiration date.D4 - unique identifier (udi) #: previously submitted as blank and now has been updated with the udi.G1 - contact office postal code: previously submitted as blank and now has been updated.H4 - device mfg date: previously submitted as blank and not has been updated.H6 - adverse event problem: has been updated as the investigation was completed.Investigation conclusion: retained devices from the reported lot number were tested with hcg-negative clinical urine and serum samples.The results were read at 3 and 4 minutes for urine samples and 5 and 6 minutes for serum samples.All devices yielded valid negative results.No false positive results were observed during in-house testing.The case details were reviewed along with the complaint history for the reported issue and no indications of a systemic issue were identified.Manufacturing batch record review did not uncover any relevant non-conformances and found that the lot met quality control specifications.Review of the risk management report for this product found that the reported issue is within the risk profile for this device; no new hazard has been identified.A root cause could not be determined from the available information as the reported issue was not replicated during testing of retention product.Complaints are tracked and trended on a monthly basis.Per the package insert: very low levels of hcg (less than 50 mlu/ml) are present in serum and urine specimen shortly after implantation.However, because a significant number of first trimester pregnancies terminate for natural reasons,' a test result that is weakly positive should be confirmed by retesting with a first morning serum or urine specimen collected 48 hours later.A number of conditions other than pregnancy, including trophoblastic disease and certain non-trophoblastic neoplasms including testicular tumors, prostate cancer, breast cancer, and lung cancer, cause elevated levels of hcg.Therefore, the presence of hcg in a serum or urine specimen should not be used to diagnose pregnancy unless these conditions have been ruled out.As with any assay employing mouse antibodies, the possibility exists for interference by human anti-mouse antibodies (hama) in the specimen.Specimens from patients who have received preparations of monoclonal antibodies for diagnosis or therapy may contain hama.Such specimens may cause false positive or false negative results.This test provides a presumptive diagnosis for pregnancy.A confirmed pregnancy diagnosis should only be made by a physician after all clinical and laboratory findings have been evaluated.H3 other text : although requested, device return is not anticipated.
 
Event Description
The customer reported receiving several false positive hcg results while using kits from two lots of medline hcg combo cassette tests.The customer reported receiving positive results when negative results are expected.No further information was provided.No adverse events reported.See mdr 2027969-2023-00119 for lot 0000674186.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MEDLINE HCG COMBO CASSETTE
Type of Device
VISUAL, PREGNANCY HCG, PRESCRIPTION USE
Manufacturer (Section D)
ALERE SAN DIEGO, INC.
9942 mesa rim rd
san diego CA 92121
Manufacturer Contact
monika burrell
9942 mesa rim rd
san diego, CA 92121
8588052506
MDR Report Key18270754
MDR Text Key329758411
Report Number2027969-2023-00120
Device Sequence Number1
Product Code JHI
UDI-Device Identifier30884389191884
UDI-Public(01)30884389191884(17)250130(10)0000674182
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K062361
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Distributor
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 12/14/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/05/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberFHC-A202
Device Catalogue NumberMPH22025HCG
Device Lot Number0000674182
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received12/13/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/06/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient SexFemale
-
-